Antidiabetic effect of an active fraction extracted from dragon's blood (Dracaena cochinchinensis)

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 1, 2009, Pages 136-139

  Gu, Hui Juan ^a   Lv, Jing Ci ^a   Yong, Ke Lan ^a   Chen, Xu ^a   Liu, Pei Pei ^a   Zhang, Xia Bing ^a  

^a SHANGHAI UNIVERSITY   (China)

Author keywords

glucosidase; Active fraction; Dragon's blood; Enzyme kinetics; Extraction; Inhibition

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; CARBOHYDRATE; DRACAENA COCHINCHINENSIS EXTRACT; GLIQUIDONE; GLUCOSE; HERBACEOUS AGENT; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE ABSORPTION; CONTROLLED STUDY; DIABETES MELLITUS; DRACAENA; DRACAENA COCHINCHINENSIS; DRUG EFFICACY; DRUG ISOLATION; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; FRACTIONATION; GLUCOSE BLOOD LEVEL; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACARBOSE; ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DRACAENA; ENZYME INHIBITORS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; MICE; PLANT EXTRACTS;

DRACAENA COCHINCHINENSIS; MUS;

EID: 58949089699     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360801936399     Document Type: Article

References (14)

1. Tu, PF, Tao, J. Hu, YQ et al. (2003) Flavones from the Wood Dracaena conchinchinensis. 1, pp. 27-29.
2. Zhang, Q. and Zhu, H. (2004) Latest Study on the dragon's blood. Acta Academjae Medicinae CPAPF, 13, pp. 69-71.
3. Orchard, TJ, Forrest, KY, Ellis, D. and Becker, DJ (1997) Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited. Arch Intern Med, 157, pp. 1851-1856.
4. Corry, DB and Tuck, ML (2000) Protection from vascular risk in diabetic hypertension. Curr Hypertension Rep, 2, pp. 154-159.
5. Stratton, IM, Adler, AI, Neil, HA, Matthews, DR, Manley, SE, Cull, CA, Hadden, D., Turner, RC and Holman, RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. 321, pp. 405-412.
6. Chen, LH, Ma, QY and Yang, B. (2005) Study on α- glucos idase inhibitor. Food Science and Technology, 8, pp. 91-94.
7. Krasikov, VV, Karelov, DV and Firsov, L. (2001) α-Glucosidases. Biochemistry (Moscow), 66, pp. 267-281.
8. Johnston, PS, Lebovitz, HE, Coniff, RF, Simonson, DC, Raskin, P. and Munera, CL (1998) Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients. J Clin Endocrinol Metab, 83, pp. 1515-1522.
9. Saito, N., Sakai, H., Suzuki, S., Sekihara, H. and Yajima, Y. (1998) Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients. J Internat Med Res, 26, pp. 219-232.
10. Standl, E., Baumgartl, HJ, Fuchtenbusch, M. and Stemplinger, J. (1997) Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diab Obes Metab, 1, pp. 215-220.
11. Shim, Y-J, Doo, H-K, Ahn, S-Y, Kim, Y-S, Seong, J-K, Park, I-S and Min, B-H (2003) Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. J Ethnopharmacol, 85, pp. 283-287.
12. Matsui, T., Ueda, T., Oki, T., Sugita, K., Terahara, N. and Matsumoto, K. (2001) alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J Agricul Food Chem, 49, pp. 1948-1951.
13. Miki, T., Tashiro, F., Iwanaga, T., Nagashima, K., Yoshitomi, H., Aihara, H., Nitta, Y., Gonoi, T., Inagaki, N., Miyazaki, J-I and Seino, S. (1997) Abnormalities of pancreatic islets by targeted expression of a dominant-negative KATP channel. Proc Natl Acad Sci, 94, pp. 11969-11973.
14. Seino, S., Iwanaga, T., Nagashima, K. and Miki, T. (2000) Diverse roles of KATP channels learned from Kir6.2 genetically engineered mice. Diabetes, 49, pp. 311-318.